Jasmanda Wu
4PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Nov 25, 2020
How many people with type 2 diabetes fulfil the eligibility criteria for randomized, controlled trials of insulin glargine 300 U/mL in a real-world setting?Dídac Mauricio, Jukka Westerbacka, Charlie Nicholls
|Jul 13, 2019
Early hypoglycaemia and adherence after basal insulin initiation in a nationally representative sample of Medicare beneficiaries with type 2 diabetes.Pengxiang Li, Zhi Geng, Vrushabh P Ladage
|Jul 03, 2019
Switching to insulin glargine 300 units/mL in real-world older patients with type 2 diabetes (DELIVER 3).Timothy S Bailey, Jasmanda Wu, Fang L Zhou
|May 31, 2019
Comparable glycaemic control and hypoglycaemia in adults with type 2 diabetes after initiating insulin glargine 300 units/mL or insulin degludec: The DELIVER Naïve D real-world study.Sean D Sullivan, Charlie J Nicholls, Rishab A Gupta
Pageof 1
